Keeping Your Cards Updated and Compliant
With new antimicrobials coming into the market, it is more important than ever to ensure adherence to standards for breakpoint determination and testing protocols. bioMérieux understands this urgency and has worked tirelessly to update the gram-negative antimicrobial susceptibility testing (AST) cards for VITEK 2 so that they better align with the evolving antimicrobial landscape.
Product availability varies by country. Consult your bioMérieux representative.
BMX.1.156998
©2025 bioMérieux, Inc. • Patents • 515 Colorow Drive, Salt Lake City, UT 84108 • Tel: (800) 634-7656 • www.biomerieux-usa.com
Lower Respiratory Tract Infection Solutions
Explore More Respiratory Topics
Pneumonia patients are frequently given empiric, broad-spectrum antimicrobial therapy while awaiting diagnostic results. This can lead to overuse of antimicrobials. Diagnostic solutions from bioMérieux provide fast pathogen detection and support effective antimicrobial therapy management.
Fast and comprehensive, the BIOFIRE RP2.1 Panel identifies 22 of the most common respiratory pathogens, including SARS-CoV-2, influenza, and respiratory syncytial virus. Rapid respiratory results may enable better-informed diagnosis, treatment, and patient management decisions.
US FDA cleared
BIOFIRE® Respiratory 2.1 (RP2.1) Panel
1 Test. 22 Targets. ~45 Minutes.
VIDAS® B•R•A•H•M•S PCTTM
Procalcitonin (PCT) is a biomarker in the blood that indicates the presence of possible bacterial infection. In patients with bacterial pneumonia, PCT levels are typically elevated in tandem with the severity of the illness. On the other hand, PCT levels do not tend to rise significantly with viral infections or noninfectious inflammation. This makes PCT an especially useful tool for diagnosing and targeting treatment for patients with lower respiratory tract infections.
VIDAS B•R•A•H•M•S PCT is an innovative assay that tests for PCT levels in just 20 minutes. By delivering accurate results quickly, it can be used to help determine the best diagnostic and treatment options for patients who present with lower respiratory tract infections. Importantly, VIDAS B•R•A•H•M•S PCT has been cleared by the FDA to aid in decision making on safe antibiotic discontinuation for patients with suspected or confirmed lower respiratory tract infection.
BIOFIRE® FILMARRAY® Pneumonia (PN) Panel
1 Test. 33 Targets. ~1 Hour.
Pneumonia patients are frequently over-treated with antibiotics because it is difficult to quickly identify the pathogen responsible for their symptoms. The BIOFIRE PN Panel delivers fast, accurate pathogen identification in about one hour, which may allow physicians to put patients on appropriate therapy quicker.
US FDA cleared
Upper Respiratory Tract Infection Solution
Upper respiratory infections often present with symptoms like coughing, congestion, and headache, which can be caused by several different respiratory pathogens. That’s why syndromic testing from bioMérieux identifies a broad range of probable pathogens in one quick test.
Watch Now: What’s New with VITEK 2?
Our experts break down everything you need to know about the new gram-negative AST cards, how they stack against the old cards, and why the switch is vital to your laboratory.
VIDAS®
B•R•A•H•M•S PCTTM
~20 minutes.
Helpful Resources
White paper: VITEK® 2 Antimicrobial Susceptibility Test Card Clinical Rationale
Letter: VITEK 2 GN-AST Card Revitalization Notification
Brochure: VITEK 2 Card Overview
Review the new card offering by clicking the button below.
VITEK® 2 & VITEK® 2 COMPACT: Antimicrobial Breakpoint Verification Guide
VITEK® 2 & VITEK® 2 COMPACT: Antimicrobial Breakpoint Validation Guide
To begin your order, please contact your bioMérieux representative. Alternatively, you may visit the bioMérieux eShop below.
How to Order
VITEK® 2 & VITEK® 2 COMPACT: Antimicrobial Breakpoint Validation Guide
Webinar: Meeting New CLSI Guidelines With VITEK 2
Watch Now: Your Questions, Answered -Everything You Need to Know about the VITEK® 2 GN Card Transition
VITEK QC ORGANISM: ATTC BAA 3144 Permit Guide
Watch Now: VITEK 2 Gram-negative AST Cards Webinar
Webinar: Your Questions, Answered -Everything You Need to Know about the VITEK® 2 GN Card Transition
Watch Now: Your Questions, Answered -Everything You Need to Know about the VITEK® 2 GN Card Transition
Webinar: Your Questions, Answered - Best Practices of Transitioning your VITEK® 2 GN AST Cards
Watch Now: Your Questions, Answered - Best Practices of Transitioning your VITEK® 2 GN AST Cards
Want to Learn More?
Fill out the form below to have a representative reach out to you.